Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancerTakahisa Yamashita, Jun‐ichi Tamaru|International Journal of Oncology|2017Cited by 30
Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non‐Muscle Invasive Bladder CancerTakahisa Yamashita, Shuji Momose|Pathology International|2025Cited by 2